Clinical Trial Update: Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

View source ↗

Summary

This clinical trial update describes an expanded access protocol using alpha/beta T and CD19+ depleted peripheral blood stem cells. It targets leukemia, bone ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure
• Immunodeficiency
• Leukemia

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Leukemia, Bone Marrow Failure Syndrome | Status: AVAILABLE